"Budget Impact of Increased Payer Adoption of the Flexitouch Advanced Pneumatic Compression Device in Lymphedema Patients"

Journal of Medical Economics, July 2018

Budget impact was calculated over 2 years for a hypothetical US payer with 10-million commercial members. Model inputs were derived from published sources and from a case-matched analysis of Blue Health Intelligence® (BHI®) claims data for the years 2012-2016.

Read the article

"Budget Impact of Increased Payer Adoption of the Flexitouch Advanced Pneumatic Compression Device in Lymphedema Patients"

You might also like

“Delay to TKA in Patients Treated with a Multimodal Approach …”

“Delay to TKA and Costs Associated with Knee Osteoarthritis Care Using Intra-Articular Hyaluronic Acid: Analysis of an Administrative Database”

“Knee OA cost comparison for hyaluronic acid and knee arthroplasty”

“Medical Utilization Surrounding Initial Opioid-Related Diagnoses by Coding Method”

“Lymphedema-associated comorbidities and treatment gap”

“Budget Impact of a Steroid-Eluting Sinus Implant Versus Sinus Surgery for Adult Chronic Sinusitis Patients with Nasal Polyps”

“The Influence of Physician Payments on the Method of Breast Reconstruction”

“Benefits of Advanced Pneumatic Compression Devices in Patients with Phlebolymphedema”

“Trends in Physician Payments for Breast Reconstruction”

“Disease-related Expenditures in Chronic Rhinosinusitis Patients After Endoscopic Sinus Surgery”

How can we help YOU drive value and innovation?

Data You Can Trust. Results You Can Count On.

About Blue Health Intelligence

Solutions for Plans

Real-World Evidence

Contact Us

Privacy

Follow